Pillstats
Rx only · Inhalant · Respiratory (Inhalation)

Acetylcysteine

Acetylcysteine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)197
US makers2 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.709$1.42$2.13$2.83Dec 2025Apr 2026Jul 2026
$2.437
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8131.6K2.4K3.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.1K
Rx · 2026 Q1
171K
Units dispensed
-61%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
American Regent, Inc.unknown4SUPPLYING
Cardinal Health 107, LLCunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.